Serum Metabolomic Profiles in Neonatal Mice following Oral Brominated Flame Retardant Exposures to Hexabromocyclododecane (HBCD) Alpha, Gamma, and Commercial Mixture

• David T. Szabo ^[2] ; Wimal Pathmasiri ^[3] ; Susan Sumner ^[3] ; Linda S. Birnbaum ^[1]
  1. [1] National Institute of Environmental Health Sciences

     National Institute of Environmental Health Sciences

     Township of Durham, Estados Unidos

     
  2. [2] 1 National Human Environmental Exposure Research Laboratory, U.S. Environmental Protection Agency (EPA), Research Triangle Park, North Carolina, USA; 2 Curriculum in Toxicology, University of North Carolina–Chapel Hill, Chapel Hill, North Carolina, USA
  3. [3] 3 Discovery Sciences, Research Triangle Institute International, Research Triangle Park, North Carolina, USA

  Mostrar afiliaciones +
• Localización: Environmental health perspectives, ISSN 0091-6765, Vol. 125, Nº. 4, 2017, págs. 651-659
• Idioma: inglés
• DOI: 10.1289/EHP242
• Enlaces
  • Texto completo
• Resumen

  • Hexabromocyclododecane (HBCD) is a high production volume brominated flame retardant added to building insulation foams, electronics, and textiles. HBCD is a commercial mixture (CM-HBCD) composed of three main stereoisomers: α-HBCD (10%), β-HBCD (10%), and γ-HBCD (80%). A shift from the dominant stereoisomer γ-HBCD to α-HBCD is detected in humans and wildlife.

    Considering CM-HBCD has been implicated in neurodevelopment and endocrine disruption, with expected metabolism perturbations, we performed metabolomics on mice serum obtained during a window-of-developmental neurotoxicity to draw correlations between early-life exposures and developmental outcomes and to predict health risks.

    Six female C57BL/6 mice at postnatal day (PND) 10 were administered a single gavage dose of α-, γ-, or CM-HBCD at 3, 10, and 30 mg/kg. Nuclear magnetic resonance metabolomics was used to analyze 60 μL serum aliquots of blood collected 4 days post-oral exposure.

    Infantile mice exposed to α-, γ-, or CM-HBCD demonstrated differences in endogenous metabolites by treatment and dose groups, including metabolites involved in glycolysis, gluconeogenesis, lipid metabolism, citric acid cycle, and neurodevelopment. Ketone bodies, 3-hydroxybutyrate, and acetoacetate, were nonstatistically elevated, when compared with mean control levels, in all treatment and dose groups, while glucose, pyruvate, and alanine varied. Acetoacetate was significantly increased in the 10 mg/kg α-HBCD and was nonsignificantly decreased with CM-HBCD. A third ketone body, acetone, was significantly lower in the 30 mg/kg α-HBCD group with significant increases in pyruvate at the same treatment and dose group. Metabolites significant in differentiating treatment and dose groups were also identified, including decreases in amino acids glutamate (excitatory neurotransmitter in learning and memory) and phenylalanine (neurotransmitter precursor) after α-HBCD and γ-HBCD exposure, respectively.

    We demonstrated that 4 days following a single neonatal oral exposure to α-, γ-, and CM-HBCD resulted in different serum metabolomic profiles, indicating stereoisomer- and mixture-specific effects and possible mechanisms of action.

    Szabo DT, Pathmasiri W, Sumner S, Birnbaum LS. 2017. Serum metabolomic profiles in neonatal mice following oral brominated flame retardant exposures to hexabromocyclododecane (HBCD) alpha, gamma, and commercial mixture. Environ Health Perspect 125:651–659; http://dx.doi.org/10.1289/EHP242

• Referencias bibliográficas
  • Ali, N, Dirtu, AC, Van den Eede, N, Goosey, E, Harrad, S, Neels, H. (2012). Occurrence of alternative flame retardants in indoor dust from...
  • Al-Mousa, F, Michelangeli, F. (2014). The sarcoplasmic-endoplasmic reticulum Ca. Chem Biol Interact. 207. 1-6
  • Asante, KA, Takahashi, S, Itai, T, Isobe, T, Devanathan, G, Muto, M. (2013). Occurrence of halogenated contaminants in inland and coastal...
  • Aylward, LL, Hays, SM. (2011). Biomonitoring-based risk assessment for hexabromocyclododecane (HBCD).. Int J Hyg Environ Health. 214. 179-187
  • Beckonert, O, Keun, HC, Ebbels, TM, Bundy, J, Holmes, E, Lindon, JC. (2007). Metabolic profiling, metabolomic and metabonomic procedures for...
  • Brosnan, JT, da Silva, RP, Brosnan, ME. (2011). The metabolic burden of creatine synthesis.. Amino Acids. 40. 1325-1331
  • Cantón, RF, Peijnenburg, AA, Hoogenboom, RL, Piersma, AH, van der Ven, LT, van den Berg, M. (2008). Subacute effects of hexabromocyclododecane...
  • (2015). Enhancing Trilateral Understanding of Chemicals in Products in North America.. CEC. Montreal, Canada.
  • Covaci, A, Gerecke, AC, Law, RJ, Voorspoels, S, Kohler, M, Heeb, NV. (2006). Hexabromocyclododecanes (HBCDs) in the environment and humans:...
  • (2008). Scientific Committe on Health and Environmental Risks (SCHER). Risk Assessment Report on Hexabomocyclododecane, Environmental Part....
  • (2009). ECHA. Helsinki, Finland.
  • Eljarrat, E, Gorga, M, Gasser, M, Díaz-Ferrero, J, Barceló, D. (2014). Dietary exposure assessment of Spanish citizens to hexabromocyclododecane...
  • Ema, M, Fujii, S, Hirata-Koizumi, M, Matsumoto, K. (2008). Two-generation reproductive toxicity study of the flame retardant hexabromocyclododecane...
  • (2013). Umetrics Academy. Malmö, Sweden.
  • Eriksson, P, Fischer, C, Wallin, M, Jakobsson, E, Fredriksson, A. (2006). Impaired behaviour, learning and memory, in adult mice neonatally...
  • Fernstrom, JD, Fernstrom, MH. (2007). Tyrosine, phenylalanine, and catecholamine synthesis and function in the brain.. J Nutr. 137. 1539-1547
  • Fromme, H, Hilger, B, Kopp, E, Miserok, M, Völkel, W. (2014). Polybrominated diphenyl ethers (PBDEs), hexabromocyclododecane (HBCD) and “novel”...
  • Hakk, H, Szabo, DT, Huwe, J, Diliberto, J, Birnbaum, LS. (2012). Novel and distinct metabolites identified following a single oral dose of...
  • Hawdon, JM. (1999). Hypoglycaemia and the neonatal brain.. Eur J Pediatr. 158. 9-12
  • Heeb, NV, Schweizer, WB, Kohler, M, Gerecke, AC. (2005). Structure elucidation of hexabromocyclododecanes—a class of compounds with a complex...
  • Herrera, E, Amusquivar, E. (2000). Lipid metabolism in the fetus and the newborn.. Diabetes Metab Res Rev. 16. 202-210
  • Kalachova, K, Hradkova, P, Lankova, D, Hajslova, J, Pulkrabova, J. (2012). Occurrence of brominated flame retardants in household and car...
  • La Merrill, M, Birnbaum, LS. (2011). Childhood obesity and environmental chemicals.. Mt Sinai J Med. 78. 22-48
  • McKenna, MC, Scafidi, S, Robertson, CL. (2015). Metabolic alterations in developing brain after injury: knowns and unknowns.. Neurochem Res....
  • (2015). Creatine deficiency syndromes. In:. University of Washington, Seattle, 2009. Seattle, WA.
  • Merrick, BA, London, RE, Bushel, PR, Grissom, SF, Paules, RS. (2011). Platforms for biomarker analysis using high-throughput approaches in...
  • Miller-Rhodes, P, Popescu, M, Goeke, C, Tirabassi, T, Johnson, L, Markowski, VP. (2014). Prenatal exposure to the brominated flame retardant...
  • Muoio, DM, Newgard, CB. (2006). Obesity-related derangements in metabolic regulation.. Annu Rev Biochem. 75. 367-401
  • Ni, HG, Zeng, H. (2013). HBCD and TBBPA in particulate phase of indoor air in Shenzhen, China.. Sci Total Environ. 1. 458-460
  • Pathmasiri, W, Pratt, KJ, Collier, ND, Lutes, LD, McRitchie, S, Sumner, SCJ. (2012). Integrating metabolomic signatures and psychosocial parameters...
  • Rasinger, JD, Carroll, TS, Lundebye, AK, Hogstrand, C. (2014). Cross-omics gene and protein expression profiling in juvenile female mice highlights...
  • Rawn, DF, Gaertner, DW, Weber, D, Curran, IH, Cooke, GM, Goodyer, CG. (2014). Hexabromocyclododecane concentrations in Canadian human fetal...
  • Saegusa, Y, Fujimoto, H, Woo, GH, Inoue, K, Takahashi, M, Mitsumori, K. (2009). Developmental toxicity of brominated flame retardants, tetrabromobisphenol...
  • Shoeib, M, Harner, T, Webster, GM, Sverko, E, Cheng, Y. (2012). Legacy and current-use flame retardants in house dust from Vancouver, Canada.....
  • Stanton, PK, Sarvey, JM. (1985). Depletion of norepinephrine, but not serotonin, reduces long-term potentiation in the dentate gyrus of rat...
  • Stockler, S, Schutz, PW, Salomons, GS. (2007). Cerebral creatine deficiency syndromes: clinical aspects, treatment and pathophysiology.. Subcell...
  • Sumner, SC, Fennell, TR, Snyder, RW, Taylor, GF, Lewin, AH. (2010). Distribution of carbon-14 labeled C60 ([. J Appl Toxicol. 30. 354-360
  • Szabo, DT, Diliberto, JJ, Hakk, H, Huwe, JK, Birnbaum, LS. (2010). Toxicokinetics of the flame retardant hexabromocyclododecane gamma: effect...
  • Szabo, DT, Diliberto, JJ, Hakk, H, Huwe, JK, Birnbaum, LS. (2011). Toxicokinetics of the flame retardant hexabromocyclododecane alpha: effect...
  • Szabo, DT, Diliberto, JJ, Huwe, JK, Birnbaum, LS. (2011). Differences in tissue distribution of HBCD alpha and gamma between adult and developing...
  • Tarnopolsky, MA, Beal, MF. (2001). Potential for creatine and other therapies targeting cellular energy dysfunction in neurological disorders.....
  • Trygg, J, Holmes, E, Lundstedt, T. (2007). Chemometrics in metabonomics.. J Proteome Res. 6. 469-479
  • (2014). U.S. EPA. Washington, DC.
  • (2014). Toxic Release Inventory (TRI) Program. TRI-Listed Chemicals..
  • (2015). IRISTrack Detailed Report.. U.S. EPA. Washington, DC.
  • van der Ven, LT, Verhoef, A, van der Kuil, T, Slob, W, Leonards, PE, Visser, TJ. (2006). A 28-day oral dose toxicity study enhanced to detect...
  • Weljie, AM, Newton, J, Mercier, P, Carlson, E, Slupsky, CM. (2006). Targeted profiling: quantitative analysis of. Anal Chem. 78. 4430-4442